SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

ALT — Altimmune, Inc.

NASDAQ

FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 6, 2025

REVENUE

$5000 0.0%

NET MARGIN

-380280.0% +62640.0 PTS

EPS

-$0.21 +22.2%

FREE CASH FLOW

-$11.9M +38.5%

No summary has been written for this call yet.